Treatment interventions for Parkinson's disease: an evidence based assessment
about
sameAs
Rasagiline for levodopa-induced motor complications in Parkinson´s diseasePiribedil for levodopa-induced complications in Parkinson's diseaseCholinesterase inhibitors for Parkinson's disease dementiaPiribedil for symptomatic management of Parkinson's diseasePiribedil versus levodopa in early Parkinson's diseaseDeep brain stimulation of subthalamic nucleus for Parkinson's diseaseCOMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson's disease (PD): relevance for motor and non-motor featuresTolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's diseaseDeep brain stimulation of subthalamic nucleus for Parkinson's diseaseRelative fundamental frequency during vocal onset and offset in older speakers with and without Parkinson's disease.Large-Scale Wearable Sensor Deployment in Parkinson's Patients: The Parkinson@Home Study Protocol.The efficacy and safety of pramipexole ER versus IR in Chinese patients with Parkinson's disease: a randomized, double-blind, double-dummy, parallel-group study.Current concepts in the diagnosis and management of Parkinson's diseaseEvaluating drug treatments for Parkinson's disease: how good are the trials?Do neurologists in Germany adhere to the national Parkinson's disease guideline?Monoamine reuptake inhibitors in Parkinson's disease.Functional improvement after subthalamic stimulation in Parkinson's disease: a non-equivalent controlled study with 12-24 month follow up.Pharmacology of orthostatic hypotension in Parkinson's disease: from pathophysiology to management.Treatment of behavioural symptoms and dementia in Parkinson's disease.Clinical experience with the novel levodopa formulation entacapone + levodopa + carbidopa (Stalevo).The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine.Rasagiline in the pharmacotherapy of Parkinson's disease--a review.A comprehensive approach to Parkinson's disease. How to manage fluctuating motor and nonmotor symptoms.Levodopa, motor fluctuations and dyskinesia in Parkinson's disease.Transdermal rotigotine: a new non-ergot dopamine agonist for the treatment of Parkinson's disease.Duodenal levodopa infusion for the treatment of Parkinson's disease.Treatment options for non-motor symptoms in late-stage Parkinson's disease.Pharmacokinetics, safety and tolerability of rotigotine transdermal patch in healthy Japanese and Caucasian subjects.Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management.Dopamine agonists and their role in Parkinson's disease treatment.Managing the critical problems of advanced Parkinson's disease.Quantitative electromyographic analysis of reaction time to external auditory stimuli in drug-naïve Parkinson's disease.Cell-based therapeutic approaches for Parkinson's disease: progress and perspectives.Levodopa in the treatment of Parkinson's disease: an old drug still going strong.Continuous dopaminergic stimulation and novel formulations of dopamine agonists.Milestones in Parkinson's disease therapeutics.Modelling the cost effectiveness of treatments for Parkinson's disease: a methodological review.Apomorphine and levodopa infusion therapies for advanced Parkinson's disease.Therapeutic strategies to prevent and manage dyskinesias in Parkinson's disease.Rasagiline and rapid symptomatic motor effect in Parkinson's disease: review of literature.
P2860
Q24243502-5F0392E3-69D1-427E-BEE3-77F7AC738762Q24244549-5EEF96F8-CB38-49CB-A519-C09D314795E6Q24244668-872EF248-653C-4E2F-B10D-B4866CBF8583Q24244952-582DFA22-81DF-4ED2-89D8-D5EE11021C10Q24244961-14EA7660-E654-4873-A4E8-DDCB3EDB4DEEQ24247833-F3C9C70C-1C3C-47C7-B0B4-F5C22E804CA2Q24644555-DB922A42-4DA0-472B-8E8A-A55B5C8C3AF3Q24657680-DDB6079D-676E-4A16-92E1-19483E02B961Q26471357-A5715463-1018-40F2-9226-FC2656CC8975Q30442314-C2F6A5E4-18D9-4D34-BA08-450E93293F05Q33450414-E94D2F48-A77C-441C-8E0E-27E059549E52Q34027252-1A71D3A3-A9D5-4EF3-8437-227991D75438Q34458284-B8851033-C4B5-4D60-8BC2-9B178C21488EQ34699750-F716C040-4FD6-4BE7-95FF-6F6E7EC7B1A5Q34879044-51655B5B-DC67-48C8-9105-3C61E3624606Q35165280-E50FACA2-0731-41F7-93A9-32AB1F4C7B19Q35487919-26A02FAD-D189-46C3-A95B-7826CDD5AE33Q35777401-763F0AA6-271E-4FBC-92AD-BF935E021FACQ36089350-98CB16C4-9423-49A7-8CCC-26E757F1E97AQ36107140-33B9265A-FE61-4969-9C59-ADE1A67D86A7Q36226808-9DC7BE08-FFFA-4174-9284-D9196DE68D05Q36273444-9EF61BE6-0142-42EB-8670-56542571D849Q36567733-F02EDD3F-CDC4-4D19-A8C2-6D6C122D5F4DQ36573882-F150505B-128D-40DD-8D77-182E453279F4Q36750148-87BCA3FB-8071-4B31-8E88-B6CF0F69374AQ36765792-3C937190-93A8-4A67-B2A7-B3961FA07874Q37098986-24043434-299C-40F3-B7AD-21EEA36CB815Q37506391-F5C503BF-3BC1-459E-8FD9-0C0F433BCD27Q37507973-7BD555A0-A5A7-475B-8B58-56F37A204836Q37610193-DA0F950A-493A-4A8E-BEF7-77BC1C953532Q37610215-F3928D8D-1121-4C0C-B173-0477919E2B67Q37645060-8121ADCA-3721-4EF4-B476-EDC968867BFFQ37732186-F86A6488-782F-4503-B1FE-1D1D754AD8A0Q37790274-D5B4732D-83CD-4EFA-90EC-586C1638133AQ37874192-1E42BDD9-C4BA-42AF-84B7-C13766045B38Q37882596-BCDFEC0E-14C9-4E5E-AF6D-315AB5340DB9Q37955238-654BF9BC-ABB1-4003-A227-BE9DA416442CQ38215506-2C6877FA-10F9-4C59-811D-8C3F7F306257Q38284574-59BB58D2-924E-4B48-B02C-FD66E9754B7FQ38497529-6384D8D8-21C4-4D43-A758-F1B2FD3C2B92
P2860
Treatment interventions for Parkinson's disease: an evidence based assessment
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Treatment interventions for Parkinson's disease: an evidence based assessment
@ast
Treatment interventions for Parkinson's disease: an evidence based assessment
@en
Treatment interventions for Parkinson's disease: an evidence based assessment
@nl
type
label
Treatment interventions for Parkinson's disease: an evidence based assessment
@ast
Treatment interventions for Parkinson's disease: an evidence based assessment
@en
Treatment interventions for Parkinson's disease: an evidence based assessment
@nl
prefLabel
Treatment interventions for Parkinson's disease: an evidence based assessment
@ast
Treatment interventions for Parkinson's disease: an evidence based assessment
@en
Treatment interventions for Parkinson's disease: an evidence based assessment
@nl
P50
P3181
P1433
P1476
Treatment interventions for Parkinson's disease: an evidence based assessment
@en
P2093
William Koller
P304
P3181
P356
10.1016/S0140-6736(02)08520-3
P407
P577
2002-05-04T00:00:00Z